These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27074775)

  • 1. ECG Features Associated With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation: A Combined AFFIRM and AF-CHF Analysis.
    Andrade JG; Roy D; Wyse DG; Dorian P; Talajic M; Leduc H; Cadrin-Tourigny J; Shohoudi A; Macle L; Thibault B; Guerra PG; Rivard L; Dubuc M; Khairy P
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):404-13. PubMed ID: 27074775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate and adverse outcomes in patients with atrial fibrillation: A combined AFFIRM and AF-CHF substudy.
    Andrade JG; Roy D; Wyse DG; Tardif JC; Talajic M; Leduc H; Tourigny JC; Shohoudi A; Dubuc M; Rivard L; Guerra PG; Thibault B; Dyrda K; Macle L; Khairy P
    Heart Rhythm; 2016 Jan; 13(1):54-61. PubMed ID: 26299677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.
    Cadrin-Tourigny J; Wyse DG; Roy D; Blondeau L; Levesque S; Talajic M; Andrade JG; Dubuc M; Thibault B; Guerra PG; Macle L; Rivard L; Khairy P
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1306-13. PubMed ID: 25181386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Shah J; Morales G; Leung SW; Fornwalt B; Bailey AL; Ziada K; Sorrell VL; Zegarra MM; Thompson J; Hosn NA; Campbell CL; Gurley J; Anaya P; Booth DC; Di Biase L; Natale A; Smyth S; Moliterno DJ; Elayi CS;
    Europace; 2014 Jun; 16(6):803-11. PubMed ID: 24368753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers.
    Gonzalez M; Keating RJ; Markowitz SM; Liu CF; Thomas G; Ip JE; Lerman BB; Cheung JW
    Heart Rhythm; 2014 Dec; 11(12):2214-21. PubMed ID: 25131667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QTc interval, cardiovascular events and mortality in patients with atrial fibrillation.
    Reusser A; Blum S; Aeschbacher S; Eggimann L; Ammann P; Erne P; Moschovitis G; Di Valentino M; Shah D; Schläpfer J; Manser S; Reichlin T; Kühne M; Sticherling C; Osswald S; Conen D
    Int J Cardiol; 2018 Feb; 252():101-105. PubMed ID: 29203211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
    Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Guan N; Zhu Z; Kowey PR; Allen LA; Fonarow GC; Hylek EM; Mahaffey KW; Freeman JV; Chang P; Holmes DN; Peterson ED; Piccini JP; Gersh BJ;
    Am Heart J; 2015 May; 169(5):647-654.e2. PubMed ID: 25965712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
    Baturova MA; Lindgren A; Carlson J; Shubik YV; Olsson SB; Platonov PG
    Int J Cardiol; 2015 Nov; 199():248-52. PubMed ID: 26209828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
    Okin PM; Bang CN; Wachtell K; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):243-51. PubMed ID: 23403268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of present atrial fibrillation on a single office electrocardiogram in patients with atrial fibrillation.
    Krisai P; Hämmerle P; Blum S; Meyre P; Aeschbacher S; Melchiorre-Mayer P; Baretella O; Rodondi N; Conen D; Osswald S; Kühne M; Zuern CS;
    J Intern Med; 2021 Mar; 289(3):395-403. PubMed ID: 32914467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events.
    Chong BH; Pong V; Lam KF; Liu S; Zuo ML; Lau YF; Lau CP; Tse HF; Siu CW
    Europace; 2012 Jul; 14(7):942-7. PubMed ID: 22183750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
    Schlatzer C; Bratton DJ; Craig SE; Kohler M; Stradling JR
    BMJ Open; 2016 Mar; 6(3):e010150. PubMed ID: 26983946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lipid-lowering therapy on outcomes in atrial fibrillation.
    Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
    Am J Cardiol; 2010 Jun; 105(12):1768-72. PubMed ID: 20538128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.
    Van Gelder IC; Wyse DG; Chandler ML; Cooper HA; Olshansky B; Hagens VE; Crijns HJ;
    Europace; 2006 Nov; 8(11):935-42. PubMed ID: 16973686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.